Cross-linked fibrin degradation product; elevated when intravascular fibrin formation and breakdown has occurred. Primary use is to rule out VTE (DVT/PE) in low-to-moderate pre-test probability.
| Sex | Age | Range | Notes |
|---|---|---|---|
| All | ≥ 18 yrs | < 500 | Standard threshold <500 µg/L FEU (age-adjusted: >50 years: age × 10 µg/L FEU reduces false positives) |
⚠ Clinical Note
Reference ranges are indicative. Always interpret results in the context of the individual patient and local laboratory reference intervals, which may vary.